Orally Disintegrating Tablets (ODTs) have emerged as one of the most innovative and rapidly growing dosage forms in modern pharmaceutical and nutraceutical sciences. Designed to disintegrate rapidly in the oral cavity with or without water, ODTs improve patient compliance, therapeutic effectiveness, convenience, and overall treatment experience. This comprehensive two-volume series presents a multidisciplinary overview of ODT technologies, encompassing fundamental principles, formulation strategies, advanced excipient systems, taste-masking approaches, Quality-by-Design (QbD) concepts, moisture-protective packaging, stability considerations, and commercialization aspects. The book further highlights emerging innovations, including nanotechnology-enabled ODTs, personalized medicine, precision dosing, effervescent tablets (Eff-Tabs), orally dissolving films (OTFs), orally dissolving webs (ODWs), and advanced 3D/4D printing technologies that are reshaping the future of oral drug delivery. The series also discusses the role of ODTs in improving bioavailability, enabling rapid onset of action, enhancing patient adherence, and supporting emerging polypill approaches for complex therapies and global regulatory requirements across more than fifty countries, providing valuable translational and industrial perspectives. This series stands among the first integrated and dedicated reference on ODT. Authored by internationally recognized experts, this landmark series serves as a comprehensive and up-to-date resource for researchers, formulation scientists, clinicians, industrial professionals, regulatory experts, and postgraduate students working in the field of advanced oral drug delivery systems.
Key Features
• Comprehensive coverage of ODTs from fundamental concepts to advanced formulation in pediatric, geriatric, neurological, cardiovascular, psychiatric, and chronic disease management
• Highlights emerging innovations, including nanotechnology-based ODTs, Eff-Tabs, OTFs, ODWs, and 3D/4D printed dosage systems
• Covers QbD strategies, specialized excipients, taste masking, stability, regulatory frameworks, and clinical evaluation
Orally Disintegrating Tablets (ODTs) have emerged as one of the most innovative and rapidly growing dosage forms in modern pharmaceutical and nutraceutical sciences. Designed to disintegrate rapidly in the oral cavity with or without water, ODTs improve patient compliance, therapeutic effectiveness, convenience, and overall treatment experience. This comprehensive two-volume series presents a multidisciplinary overview of ODT technologies, encompassing fundamental principles, formulation strategies, advanced excipient systems, taste-masking approaches, Quality-by-Design (QbD) concepts, moisture-protective packaging, stability considerations, and commercialization aspects. The book further highlights emerging innovations, including nanotechnology-enabled ODTs, personalized medicine, precision dosing, effervescent tablets (Eff-Tabs), orally dissolving films (OTFs), orally dissolving webs (ODWs), and advanced 3D/4D printing technologies that are reshaping the future of oral drug delivery. The series also discusses the role of ODTs in improving bioavailability, enabling rapid onset of action, enhancing patient adherence, and supporting emerging polypill approaches for complex therapies and global regulatory requirements across more than fifty countries, providing valuable translational and industrial perspectives. This series stands among the first integrated and dedicated reference on ODT. Authored by internationally recognized experts, this landmark series serves as a comprehensive and up-to-date resource for researchers, formulation scientists, clinicians, industrial professionals, regulatory experts, and postgraduate students working in the field of advanced oral drug delivery systems.
Key Features
• Comprehensive coverage of ODTs from fundamental concepts to advanced formulation in pediatric, geriatric, neurological, cardiovascular, psychiatric, and chronic disease management
• Highlights emerging innovations, including nanotechnology-based ODTs, Eff-Tabs, OTFs, ODWs, and 3D/4D printed dosage systems
• Covers QbD strategies, specialized excipients, taste masking, stability, regulatory frameworks, and clinical evaluation
Ranjita Shegokar
Orally dispersible tablets Orally disintegrating tablets Quick oral drug release ODT Formulation and development of ODT Excipients for ODT ODT advantages and disadvantages ODT administration Commercial products and trend setters in ODT Market ODT benefits Drug delivery in ODT and testing by 3D printing Desmopressin orally disintegrating tablets Regulatory requirements for ODT in US FDA ODT for pediatric applications ODT for geriatrics applications and chronic diseases